Combination therapy with brentuximab vedotin and cisplatin/cytarabine in a patient with primarily refractory anaplastic lymphoma kinase positive anaplastic large cell lymphoma

Simon Heidegger, Ambros Beer, Eva Geissinger, Andreas Rosenwald, Christian Peschel, Ingo Ringshausen, Ulrich Keller

Publikation: Beitrag in FachzeitschriftArtikelBegutachtung

8 Zitate (Scopus)

Fingerprint

Untersuchen Sie die Forschungsthemen von „Combination therapy with brentuximab vedotin and cisplatin/cytarabine in a patient with primarily refractory anaplastic lymphoma kinase positive anaplastic large cell lymphoma“. Zusammen bilden sie einen einzigartigen Fingerprint.

Keyphrases

Medicine and Dentistry

Pharmacology, Toxicology and Pharmaceutical Science